Mark Goldsmith

Track

Insider profile

Currently holds positions in Revolution Medicines Inc and Constellation Pharmaceuticals Inc

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 64% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Founding President, Chief Executive Officer, Board Director Revolution Medicines Inc None -
Independent Chairman of the Board Constellation Pharmaceuticals Inc July 1, 2009 -
Chairman of the Board Nurix Therapeutics Inc Sept. 18, 2014 - Jan. 1, 2016
Chairman of the Board, Chief Executive Officer Nurix Therapeutics Inc None -
Chief Executive Officer, Board Member Global Blood Therapeutics Inc None -
Mark Goldsmith's trades of Revolution Medicines Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
499.62
Quantity 59,157
Value US$2,889,067
Transaction date
Proposed sale
Price
211.74
Quantity 80,000
Value US$16,938,800
Transaction date
Proposed sale
Price
211.74
Quantity 3,000
Value US$635,205
Transaction date
Proposed sale
Price
211.74
Quantity 3,000
Value US$635,205
Transaction date
Proposed sale
Price
153.87
Quantity 9,772
Value US$1,503,618
Transaction date
Proposed sale
Price
147.01
Quantity 120,000
Value US$17,641,200
Transaction date
Proposed sale
Price
99.59
Quantity 13,261
Value US$1,320,663
Transaction date
Proposed sale
Price
102.02
Quantity 3,000
Value US$306,060
Transaction date
Proposed sale
Price
102.02
Quantity 3,000
Value US$306,060
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-18 2026-09-16
PlS Planned sale
49,615 -30.8%
188.18
US$4,482,890 		49,615 -30.8% 188.18 US$4,482,890
2026-09-18 2026-09-16
PlS Planned sale
62,650 +40.0%
253.29
US$622,903 		62,650 +40.0% 253.29 US$622,903
2026-09-15 2026-09-15
PrS Proposed sale
59,157
499.62
US$2,889,067 		59,157 499.62 US$2,889,067
2026-08-25 2026-08-21
S Sale
126 -0.2%
212.06
US$26,720 		126 -0.2% 212.06 US$26,720
2026-08-25 2026-08-21
S Sale
229 -0.4%
211.46
US$48,425 		229 -0.4% 211.46 US$48,425
2026-08-25 2026-08-21
S Sale
126 -0.2%
210.40
US$26,511 		126 -0.2% 210.40 US$26,511
2026-08-25 2026-08-21
S Sale
1,405 -2.2%
209.27
US$294,019 		1,405 -2.2% 209.27 US$294,019
2026-08-25 2026-08-21
S Sale
937 -1.5%
208.36
US$195,234 		937 -1.5% 208.36 US$195,234
2026-08-25 2026-08-21
S Sale
177 -0.3%
207.25
US$36,684 		177 -0.3% 207.25 US$36,684
2026-08-25 2026-08-21
S Sale
127 -0.2%
212.06
US$26,932 		127 -0.2% 212.06 US$26,932
2026-08-25 2026-08-21
S Sale
245 -0.4%
211.47
US$51,809 		245 -0.4% 211.47 US$51,809
2026-08-25 2026-08-21
S Sale
136 -0.2%
210.40
US$28,615 		136 -0.2% 210.40 US$28,615
2026-08-25 2026-08-21
S Sale
1,351 -2.1%
209.28
US$282,739 		1,351 -2.1% 209.28 US$282,739
2026-08-25 2026-08-21
S Sale
951 -1.5%
208.36
US$198,155 		951 -1.5% 208.36 US$198,155
2026-08-25 2026-08-21
S Sale
190 -0.3%
207.25
US$39,377 		190 -0.3% 207.25 US$39,377
2026-08-25 2026-08-21
PlS Planned sale
3,621 -1.3%
212.08
US$767,933 		3,621 -1.3% 212.08 US$767,933
2026-08-25 2026-08-21
PlS Planned sale
6,583 -2.4%
211.33
US$1,391,206 		6,583 -2.4% 211.33 US$1,391,206
2026-08-25 2026-08-21
PlS Planned sale
3,813 -1.4%
210.25
US$801,670 		3,813 -1.4% 210.25 US$801,670
2026-08-25 2026-08-21
PlS Planned sale
35,938 -11.3%
209.26
US$7,520,440 		35,938 -11.3% 209.26 US$7,520,440
2026-08-25 2026-08-21
PlS Planned sale
24,917 -7.3%
208.37
US$5,191,948 		24,917 -7.3% 208.37 US$5,191,948
2026-08-25 2026-08-21
PlS Planned sale
5,128 -1.5%
207.23
US$1,062,691 		5,128 -1.5% 207.23 US$1,062,691
2026-08-21 2026-08-21
PrS Proposed sale
80,000
211.74
US$16,938,800 		80,000 211.74 US$16,938,800
2026-08-21 2026-08-21
PrS Proposed sale
3,000
211.74
US$635,205 		3,000 211.74 US$635,205
2026-08-21 2026-08-21
PrS Proposed sale
3,000
211.74
US$635,205 		3,000 211.74 US$635,205
2026-06-18 2026-06-16
PlS Planned sale
10,020 -3.6%
156.12
US$1,564,310 		10,020 -3.6% 156.12 US$1,564,310
2026-06-15 2026-06-15
PrS Proposed sale
9,772
153.87
US$1,503,618 		9,772 153.87 US$1,503,618
2026-04-17 2026-04-15
PlS Planned sale
120,000 -30.2%
150.09
US$18,010,488 		120,000 -30.2% 150.09 US$18,010,488
2026-04-15 2026-04-15
PrS Proposed sale
120,000
147.01
US$17,641,200 		120,000 147.01 US$17,641,200
2026-03-19 2026-03-17
PlS Planned sale
12,871 -4.4%
99.48
US$1,280,412 		12,871 -4.4% 99.48 US$1,280,412
2026-03-13 2026-03-16
PrS Proposed sale
13,261
99.59
US$1,320,663 		13,261 99.59 US$1,320,663
2026-03-03 2026-03-02
S Sale
200 -0.3%
102.08
US$20,416 		200 -0.3% 102.08 US$20,416
2026-03-03 2026-03-02
S Sale
2,100 -3.1%
101.63
US$213,432 		2,100 -3.1% 101.63 US$213,432
2026-03-03 2026-03-02
S Sale
600 -0.9%
100.19
US$60,116 		600 -0.9% 100.19 US$60,116
2026-03-03 2026-03-02
S Sale
100 -0.1%
98.29
US$9,829 		100 -0.1% 98.29 US$9,829
2026-03-03 2026-03-02
S Sale
800 -1.2%
102.00
US$81,599 		800 -1.2% 102.00 US$81,599
2026-03-03 2026-03-02
S Sale
1,700 -2.5%
101.47
US$172,506 		1,700 -2.5% 101.47 US$172,506
2026-03-03 2026-03-02
S Sale
400 -0.6%
100.12
US$40,049 		400 -0.6% 100.12 US$40,049
2026-03-03 2026-03-02
S Sale
100 -0.1%
98.31
US$9,831 		100 -0.1% 98.31 US$9,831
2026-03-03 2026-03-02
PlS Planned sale
851 -0.3%
102.20
US$86,972 		851 -0.3% 102.20 US$86,972
2026-03-03 2026-03-02
PlS Planned sale
21,329 -6.8%
101.60
US$2,167,075 		21,329 -6.8% 101.60 US$2,167,075
2026-03-03 2026-03-02
PlS Planned sale
3,620 -1.1%
100.73
US$364,659 		3,620 -1.1% 100.73 US$364,659
2026-03-03 2026-03-02
PlS Planned sale
3,500 -1.1%
99.76
US$349,150 		3,500 -1.1% 99.76 US$349,150
2026-03-03 2026-03-02
PlS Planned sale
700 -0.2%
98.17
US$68,720 		700 -0.2% 98.17 US$68,720
2026-03-02 2026-03-02
PrS Proposed sale
3,000
102.02
US$306,060 		3,000 102.02 US$306,060
2026-03-02 2026-03-02
PrS Proposed sale
3,000
102.02
US$306,060 		3,000 102.02 US$306,060